(Q26849652)

language of work or name

1 reference

2013

1 reference

1 reference

63

1 reference

PubMed

page(s)

232-48

1 reference

PubMed

issue

4

1 reference

Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005

PubMed

cites work

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Trends in esophageal adenocarcinoma incidence and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Esophageal adenocarcinoma incidence: are we reaching the peak?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

No further increase in the incidence of esophageal adenocarcinoma in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Clinical practice. Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Central adiposity and risk of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Abdominal obesity and the risk of esophageal and gastric cardia carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Obesity and cancer: the role of dysfunctional adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Body-mass index and symptoms of gastroesophageal reflux in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Systematic review: patterns of reflux-induced symptoms and esophageal endoscopic findings in large-scale surveys.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma--a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Epidemiology of Helicobacter pylori infection and public health implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The role of Helicobacter pylori infection in the web of gastric cancer causation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Red and processed meat intake and risk of esophageal adenocarcinoma: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Population attributable risks of esophageal and gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Increased risk of stomach and esophageal malignancies in people with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Sex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Sex-specific risk factor profile in oesophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Sex differences in the incidence of gastrointestinal adenocarcinoma in Sweden 1970-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The mystery of male dominance in oesophageal cancer and the potential protective role of oestrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Reproductive factors and risk of oesophageal cancer, a population-based nested case-control study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Clinical practice. Gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Medication usage and the risk of neoplasia in patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The risk of esophageal adenocarcinoma after antireflux surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Risk factors for esophageal adenocarcinoma after antireflux surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Esophagogastric cancer after bariatric surgery: systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Aspirin and cancer risk: a quantitative review to 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Prevalence of Barrett's esophagus in the general population: an endoscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Screening for oesophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

A model to determine absolute risk for esophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Incidence of adenocarcinoma among patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Predictors of progression in Barrett's esophagus: current knowledge and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Survival after surgery for oesophageal cancer: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Guidelines for the management of oesophageal and gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Evidence-based surgical treatment of esophageal cancer: overview of high-quality studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Oesophagogastric junction adenocarcinoma: which therapeutic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Systematic review of minimally invasive resection for gastro-oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Robotically assisted laparoscopic transhiatal esophagectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Evidence to support the use of minimally invasive esophagectomy for esophageal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Trends in hospital volume and operative mortality for high-risk surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Surgeon volume and operative mortality in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Variation in hospital mortality associated with inpatient surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Centralization of cancer surgery: implications for patient access to optimal care.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Surgeon volume is a poor proxy for skill in esophageal cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Impact of concentration of oesophageal and gastric cardia cancer surgery on long-term population-based survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Long-term health-related quality of life following surgery for oesophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Systematic review of health-related quality of life after esophagectomy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Systematic review: quality of life after treatment for upper gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Long-term weight change after oesophageal cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Predictors of postoperative quality of life after esophagectomy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Nutrition therapy issues in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Risk factors for malnutrition after oesophageal and cardia cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The influence of needle catheter jejunostomy on weight development after oesophageal cancer surgery in a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Chemoradiation in the management of esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Definitive chemoradiotherapy for esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Radiofrequency ablation in Barrett's esophagus with dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Endotherapy for Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The cost effectiveness of radiofrequency ablation for Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Esophageal cancer: a critical evaluation of systemic second-line therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The use of self-expanding stents in esophageal and gastroesophageal junction cancer palliation: a meta-analysis and meta-regression analysis of outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer--results of a prospective safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Diverging trends in recent population-based survival rates in oesophageal and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Influence of sex on the survival of patients with esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Genetics in the pathogenesis of esophageal cancer: possible predictive and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Genetic variations in esophageal cancer risk and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Analysis of clinical decision-making in multi-disciplinary cancer teams

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Population-based esophageal cancer survival after resection without neoadjuvant therapy: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Malnutrition after oesophageal cancer surgery in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Surgical complications and long-term survival after esophagectomy for cancer in a nationwide Swedish cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

Obesity and estrogen as risk factors for gastroesophageal reflux symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

7 January 2021

Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

7 January 2021

Health Benefits and Cost Effectiveness of Endoscopic and Nonendoscopic Cytosponge Screening for Barrett's Esophagus

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

7 January 2021

Helicobacter pylori infection: mainly foe but also friend?

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

7 January 2021

Lymph node metastasis in early esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

7 January 2021

Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

7 January 2021

Changes in age, stage distribution, and survival of patients with esophageal adenocarcinoma over three decades in the United States

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

7 January 2021

H. pylori infection and gastric cancer: state of the art (review).

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

7 January 2021

Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

7 January 2021

Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21185

7 January 2021